An inexpensive anti-microbial drug used to deal with abdomen ulcers and bacterial infections has proven promise in combating the coronavirus in animals, scientists in Hong Kong introduced Monday.
Researchers got down to discover whether or not metallodrugs — compounds containing metallic which might be extra generally used towards micro organism — may additionally have anti-viral properties that would fight the SARS-CoV-2 coronavirus.
Using Syrian hamsters as checks topics, they discovered that one of many medicine, ranitidine bismuth citrate (RBC), was “a potent anti-SARS-CoV-2 agent”.
“RBC is able to lower the viral load in the lung of the infected hamster by tenfold,” Hong Kong University researcher Runming Wang informed reporters on Monday because the crew introduced their examine.
“Our findings demonstrate that RBC is a potential anti-viral agent for COVID-19.”
The Hong Kong scientists stated RBC was a generally out there drug used towards abdomen ulcers with a protected and complete pharmacological profile.
“It’s been used for decades so it’s pretty safe,” Mr. Wang stated.
They added that their analysis has been printed within the journal Nature Microbiology.